NASDAQ: CODX - Co-Diagnostics, Inc.

छह महीने के लिए लाभप्रदता: -71.99%
भाग प्रतिफल: 0.00%
सेक्टर: Healthcare

पदोन्नति कार्यक्रम Co-Diagnostics, Inc.

उन्नत शेड्यूल सरल ग्राफ
Financial Markets by TradingView

कंपनी के बारे में Co-Diagnostics, Inc.

Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.

अधिक जानकारी
It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. The company also provides tests that identify genetic traits in plant and animal genomes; and portable PCR device designed to bring PCR to patients in point-of-care and at-home settings. In addition, it intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.
तुलना सूची में जोड़ें
घड़ी सूची में जोड़ें
पोर्टफोलियो में जोड़ें
मूल्य सूचना जोड़ें

IPO date 2017-07-12
ISIN US1897631057
Industry Health Care Equipment & Supplies
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://www.codiagnostics.com
Цена ао 0.4166
प्रति दिन मूल्य परिवर्तन: -3.42% (0.3625)
प्रति सप्ताह मूल्य परिवर्तन: +4.82% (0.334)
प्रति माह मूल्य परिवर्तन: -22.54% (0.452)
3 महीने में कीमत में बदलाव: -52.94% (0.744)
छह महीने में कीमत में बदलाव: -71.99% (1.25)
प्रति वर्ष मूल्य परिवर्तन: -69.29% (1.14)
3 वर्षों में मूल्य परिवर्तन: -93.69% (5.55)
5 वर्षों में मूल्य परिवर्तन: -96.7% (10.6)
वर्ष की शुरुआत से मूल्य परिवर्तन: -54.41% (0.768)
सभी पैरामीटर

बहुत मूल्यवान समझना

नाम अर्थ श्रेणी
P/S 34.04 1
P/BV 0.3924 10
P/E 0 0
EV/EBITDA -0.4614 0
कुल: 4.75

क्षमता

नाम अर्थ श्रेणी
ROA, % -34.09 0
ROE, % -41.08 0
कुल: 0

लाभांश

नाम अर्थ श्रेणी
Div yield, % 0 0
DSI 0 0
कुल: 0

कर्तव्य

नाम अर्थ श्रेणी
Debt/EBITDA -0.0632 10
कुल: 10

विकास का आवेग

नाम अर्थ श्रेणी
लाभप्रदता Revenue, % 3068.39 10
लाभप्रदता Ebitda, % 591.26 10
लाभप्रदता EPS, % 232.41 10
कुल: 10
अधिक जानकारी

संस्थानों आयतन शेयर करना, %
Vanguard Group Inc 1781283 5.7
Renaissance Technologies, LLC 617000 1.97
Blackrock Inc. 501830 1.61
Geode Capital Management, LLC 294422 0.94
Bridgeway Capital Management, Inc. 272900 0.87
Bank Of New York Mellon Corporation 145621 0.47
Kestra Advisory Services, LLC 138607 0.44
Susquehanna International Group, LLP 107699 0.34
State Street Corporation 100647 0.32
Citadel Advisors Llc 96647 0.31



पर्यवेक्षक नौकरी का शीर्षक भुगतान जन्म का साल
Mr. Dwight H. Egan Chairman & CEO 415.75k 1953 (72 वर्ष)
Mr. Brian L. Brown CPA CFO & Company Secretary 338.92k 1976 (49 साल)
Dr. Brent C. Satterfield Ph.D. Co-Founder & Member of Scientific Advisory Board 237.5k 1977 (48 साल)
Mr. Dan Bohrer CPA Vice President of Finance & Accounting N/A
Mr. Andrew Benson Head of Investor Relations N/A
Dr. Mayuranki Almaula Senior Vice President of Overseas Operations & Strategic Alliances N/A
Mr. Richard David Abbott President N/A 1972 (53 वर्ष)
Mr. David Nielsen Chief Operating Officer N/A
Mr. Christopher Thurston Chief Technology Officer N/A
Mr. Cameron Gundry Head of Commercialization LATAM/EUR

पता: United States, Salt Lake City. UT, 2401 South Foothill Drive - Google मानचित्र में खोलें, यांडेक्स मानचित्र खोलें
वेबसाइट: https://www.codiagnostics.com